Phytomelatonin content in Valeriana officinalis L. and some related phytotherapeutic supplements
Authors:
- Marta LosadaMLMarta Losada
- Antonio CanoACAntonio Cano
- Josefa Hernández-Rui̇zJHJosefa Hernández-Rui̇z
- Marino B. ArnaoMarino B. Arnao
Open Access
- 22 March 2022
- journal article
- research article
- Published by Bektas Tepe Publications in International Journal of Plant Based Pharmaceuticals
- Vol. 2 (2) , 176-181
Abstract
The use of medicinal plants as an alternative phytotherapeutic remedy against mild illnesses and dysfunctions is increasingly embraced by people. Among these dysfunctions, episodes of nervousness and anxiety due to lack of sleep and insomnia are becoming more and more frequent among the population. To remedy these problems, several plants with sedative activity are recommended. In particular, valerian root (Valeriana officinalis L.) is the most recommended and studied with a significant difference. This study presented a quantification of the phytomelatonin contents in valerian root and several related and recommended herb supplements against nervousness, anxiety, and insomnia. The results showed the presence of phytomelatonin in all the samples analyzed. The high phytomelatonin contents in valerian root and its supplements indicated that, in addition to the known constituents of valerian root such as valerenic acid, phytomelatonin also contributed to the phytotherapeutic activity of this plant since the relaxing and sleep-inducing activity of melatonin is well documented. The recommended daily doses of valerian are analyzed according to their phytomelatonin content, and recommendations are given on the possible synergistic action of the components of valerian as a relaxant and sleep inducer in patients with these dysfunctions. It is also recommended to document the phytomelatonin contents in phytotherapeutic preparations.Keywords
This publication has 41 references indexed in Scilit:
- Herbal medicine use in pregnancy: results of a multinational studyBMC Complementary and Alternative Medicine, 2013
- Meta-Analysis: Melatonin for the Treatment of Primary Sleep DisordersPLOS ONE, 2013
- The Use of Valeriana officinalis (Valerian) in Improving Sleep in Patients Who Are Undergoing Treatment for Cancer: A Phase III Randomized, Placebo-Controlled, Double-Blind Study (NCCTG Trial, N01C5)Journal of Supportive Oncology, 2011
- Sleep improving effects of a single dose administration of a valerian/hops fluid extract. A double blind, randomized, placebo-controlled sleep-EEG study in a parallel design using the electrohypnogramZeitschrift für Phytotherapie, 2008
- Modulation of GABAA Receptors by Valerian Extracts is Related to the Content of Valerenic AcidPlanta Medica, 2007
- Valerian for anxiety disordersCochrane Database of Systematic Reviews, 2006
- Efficient Route to the Pineal Hormone Melatonin by Radical-Based Indole SynthesisSynthetic Communications, 2003
- Microwave Assisted Synthesis of MelatoninSynthetic Communications, 2003
- Structural Characterization of Contaminants Found in Commercial Preparations of Melatonin: Similarities to Case-Related Compounds from l-Tryptophan Associated with Eosinophilia-Myalgia SyndromeChemical Research in Toxicology, 1998
- The Eosinophilia-Myalgia Syndrome: Lessons From GermanyMayo Clinic Proceedings, 1994